Insiders Myriad Genetics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
25.25 ^USD	+5.43%		+31.37%	+31.92%

05-08	Sector Update: Health Care Stocks Softer Late Afternoon	MT
05-08	Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue	MT

Myriad Genetics Names George Daneker Jr. as President, Chief Clinical Officer of Oncology	01-31	MT
Myriad Genetics, Inc. Appoints George Daneker as President and Chief Clinical Officer of Oncology, Effective March 18, 2024	01-30	CI
Myriad Genetics Names Scott Leffler as Chief Financial Officer, Reiterates Outlook	12-21	MT
Myriad Genetics Insider Sold Shares Worth $470,622, According to a Recent SEC Filing	11-03	MT
Myriad Genetics Names Sam Raha as Chief Operating Officer	11-01	MT
Myriad Genetics, Inc. Appoints Samraat S. Raha as Chief Operating Officer, Effective as of December 11, 2023	11-01	CI
Myriad Genetics COO Nicole Lambert to Step Down	23-10-05	MT
Myriad Genetics, Inc. Announces Executive Changes	23-10-05	CI
Insider Sell: Myriad Genetics	23-06-05	MT
Myriad Genetics, Inc. Appoints Adam Brufsky as Scientific Advisor	23-05-31	CI
Insider Sell: Myriad Genetics	23-03-28	MT
Insider Sell: Myriad Genetics	23-03-03	MT
Insider Sell: Myriad Genetics	23-03-03	MT
Insider Sell: Myriad Genetics	23-01-23	MT
Insider Sell: Myriad Genetics	22-12-28	MT
Myriad Genetics, Inc. Hires Senior Leaders to Advance Commercial Growth Plans	22-12-19	CI
Myriad Genetics, Inc. Elects Paul M. Bisaro as New Board Member	22-10-31	CI
Myriad Genetics, Inc. Announces the Resignation of Dennis Langer as Director	22-06-30	CI
Myriad Genetics, Inc. Announces Executive Changes	22-06-02	CI
Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies	22-03-08	GL

No results for this search